I agree that this site is using cookies. You can find further informations here.
X
Arai, Koutaro
37  results:
Search for persons X
?
1

Transformation of thioacetals to cyclopropanes:

Takeda, Takeshi ; Arai, Koutaro ; Shimokawa, Hirohisa.
Tetrahedron Letters.  46 (2005)  5 - p. 775-778 , 2005
Link: https://doi.org/10.1016/..
 
?
2

Efficacy and Safety of Pemafibrate Extended-Release Tablet:..:

Arai, Hidenori ; Yamashita, Shizuya ; Araki, Eiichi...
Journal of Atherosclerosis and Thrombosis.  , 2024
Link: https://doi.org/10.5551/..
 
?
3

Japan Atherosclerosis Society (JAS) Guidelines for Preventi..:

Okamura, Tomonori ; Tsukamoto, Kazuhisa ; Arai, Hidenori...
Journal of Atherosclerosis and Thrombosis.  31 (2024)  6 - p. 641-853 , 2024
Link: https://doi.org/10.5551/..
 
?
4

Guidelines for the Diagnosis and Treatment of Adult Familia..:

Harada-Shiba, Mariko ; Arai, Hidenori ; Ohmura, Hirotoshi...
Journal of Atherosclerosis and Thrombosis.  30 (2023)  5 - p. 558-586 , 2023
Link: https://doi.org/10.5551/..
 
?
5

Effects of pemafibrate on glucose metabolism markers and li..:

Yokote, Koutaro ; Yamashita, Shizuya ; Arai, Hidenori...
Cardiovascular Diabetology.  20 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
6

Distinct Differences in Lipoprotein Particle Number Evaluat..:

Yamashita, Shizuya ; Okazaki, Mitsuyo ; Okada, Takeshi...
Journal of Atherosclerosis and Thrombosis.  28 (2021)  9 - p. 974-996 , 2021
Link: https://doi.org/10.5551/..
 
?
7

Guidelines on the Clinical Evaluation of Medicinal Products..:

Yamashita, Shizuya ; Masuda, Daisaku ; Akishita, Masahiro...
Journal of Atherosclerosis and Thrombosis.  27 (2020)  11 - p. 1246-1254 , 2020
Link: https://doi.org/10.5551/..
 
?
8

Efficacy and Safety of Pemafibrate, a Novel Selective Perox..:

Yamashita, Shizuya ; Arai, Hidenori ; Yokote, Koutaro...
International Journal of Molecular Sciences.  20 (2019)  22 - p. 5537 , 2019
Link: https://doi.org/10.3390/..
 
?
9

Efficacy and safety of pemafibrate in people with type 2 di..:

Araki, Eiichi ; Yamashita, Shizuya ; Arai, Hidenori...
Diabetes, Obesity and Metabolism.  21 (2019)  7 - p. 1737-1744 , 2019
Link: https://doi.org/10.1111/..
 
?
10

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selec..:

Yokote, Koutaro ; Yamashita, Shizuya ; Arai, Hidenori...
International Journal of Molecular Sciences.  20 (2019)  3 - p. 706 , 2019
Link: https://doi.org/10.3390/..
 
?
11

Multidrug use positively correlates with high-risk prescrip..:

Arai, Sayaka ; Ishikawa, Takahiro ; Kato, Hisaya...
Journal of Pharmaceutical Health Care and Sciences.  5 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
12

Effects of pemafibrate (K-877) on cholesterol efflux capaci..:

Yamashita, Shizuya ; Arai, Hidenori ; Yokote, Koutaro...
Journal of Clinical Lipidology.  12 (2018)  5 - p. 1267-1279.e4 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Pa..:

Arai, Hidenori ; Yamashita, Shizuya ; Yokote, Koutaro...
Journal of Atherosclerosis and Thrombosis.  25 (2018)  6 - p. 521-538 , 2018
Link: https://doi.org/10.5551/..
 
?
14

Effects of Selective PPARα Modulator K-877 on Particle Numb..:

Yamashita, Shizuya ; Okazaki, Mitsuyo ; Okada, Takeshi...
Atherosclerosis Supplements.  32 (2018)  - p. 62-63 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Efficacy of Pemafibrate on Atherogenic Dyslipidemia: Result..:

Ishibashi, Shun ; Arai, Hidenori ; Yokote, Koutaro...
Atherosclerosis Supplements.  32 (2018)  - p. 25-26 , 2018
Link: https://doi.org/10.1016/..
 
1-15